Back to Trades
Sassi Nir
Chief Financial OfficerCIK 0001760673
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Sassi Nir, Chief Financial Officer, accounts for 1 disclosed filing worth $0, all concentrated in Nasus Pharma Ltd (NSRX), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.